Abstract
Bone marrow stromal cells are essential for the differentiation, survival and proliferation of normal and leukemic human B-lineage cells. Leukemic cells require stromal cell support for optimal proliferation and apoptotic resistance. Stromal cell contact can promote resistance to chemotherapeutic agents. In this study, we have made use of small molecular weight inhibitors and an established stromal cell-dependent pre-B-ALL cell line, BLIN-2, to investigate the role of the MAP kinase, PI3K/Akt, JAK/STAT and mTOR pathways in the promotion of leukemic cell growth in the presence of stromal cell support. Treatment with PI3K+JAK, PI3K+MEK, or MEK+JAK inhibitor combinations resulted in an inhibition of proliferation as measured by DNA synthesis. However, only inhibition of both PI3K and MEK or both mTOR and MEK resulted in a dramatic increase in the number of annexinV+/PI+ apoptotic events within a 24 h period. Our data suggest that stromal cell-mediated apoptotic protection in B-lineage ALL is mediated by PI3K/mTOR and MEK via a synergistic mechanism(s).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bertrand FE, Eckfeldt CE, Fink JR, Lysholm AS, Pribyl JA, Shah N et al. Microenvironmental influences on human B-cell development. Immunol Rev 2000; 175: 175–186.
Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC et al. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 1994; 83: 758–766.
Shah N, Oseth L, LeBien TW . Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. Blood 1998; 92: 3817–3828.
Vega F, Medeiros LJ, Lang W-H, Mansoor A, Bueso-Ramos C, Jone D . The stomal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours. Br J Haematol 2002; 117: 569–576.
Burger JA, Tsukada N, Burger M, Zvailfler NK, Dell'Aquila M, Kipps TJ . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell derived factor-1. Blood 2002; 96: 2655–2663.
Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M . Stromal cells prevent apoptosis of AML cell by up-regulation of anti-apoptotic proteins. Leukemia 2003; 16: 1713–1724.
Kumagai M, Manabe A, Coustan-Smith E, Blakley RL, Beck WT, Santana VM et al. Use of stroma-supported cultures of leukemic cells to access antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia 1994; 8: 1116–1123.
Fortney JE, Zhao W, Wenger SL, Gibson LF . Bone marrow stromal cells regulate caspase-3 activity in leukemic cells during chemotherapy. Leuk Res 2001; 25: 901–907.
Mudry RE, Fortney JE, York T, Hall BM, Gibson LF . Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000; 96: 1926–1932.
Astier AL, Xu R, Svoboda M, Hinds E, Munoz O, de Beaumont R et al. Temporal gene expression profile of human precursor B leukemic cells induced by adhesion receptor: identification of pathways regulating B-cell survival. Blood 2003; 101: 1118–1127.
Nefedova Y, Landowski TH, Dalton WS . Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cell by distinct mechanisms. Leukemia 2003; 17: 1175–1182.
Lee JT, McCubrey JA . The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002; 16: 486–507.
Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR–ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189–218.
Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moe PW et al. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene 2003; 22: 2478–2492.
Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17: 590–603.
Gingras A-C, Raught B, Soneberg N . Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15: 807–826.
Shah N, Oseth L, Tran H, Hirsch B, LeBien TW . Clonal variation in the B-lineage acute lymphoblastic leukemia response to multiple cytokines and bone marrow stromal cells. Cancer Res 2001; 61: 5268–5274.
Shelton JG, Moye PW, Steelman LS, Blalock WL, Lee JT, Franklin RA et al. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation. Leukemia 2003; 17: 1765–1782.
Blalock WL, Pearce M, Chang F, Lee JT, Pohnert SC, Burrows C et al. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia 2001; 15: 794–807.
Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M et al. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia 2000; 14: 642–656.
Creagh EM, Sheehan D, Cotter TG . Heat shock proteins – modulators of apoptosis in tumour cells. Leukemia 2000; 14: 1161–1173.
Gibson LF . Survival of B lineage leukemic cells: signals from the bone marrow microenvironment. Leuk Lymphoma 2002; 43: 19–27.
De Rossi G, Tenca C, Cerruti G, Favre A, Zarcone D, Tabilio A et al. Adhesion molecule expression on B-cells from acute and chronic lymphoid leukemias. Leuk Lymphoma 1994; 16: 31–36.
Kurosaka D, LeBien TW, Pribyl JA . Comparative studies of different stromal cell microenvironments in support of human B-cell development. Exp Hematol 1999; 27: 1271–1281.
Bertrand FE, Spengeman JD, Shah N, LeBien TW . B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression. Leukemia 2003; 17: 2454–2459.
Acknowledgements
We thank Dr Tucker LeBien and Nisha Shah (University of Minnesota Cancer Center) for the BLIN-2 cell line. FEB was supported in part by Institutional Grant ECU-5-89812 from the American Cancer Society. JAM was supported in part by grants RO1 CA51025 and RO1 CA 098195 from the US Public Health Service, National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bertrand, F., Spengemen, J., Shelton, J. et al. Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support. Leukemia 19, 98–102 (2005). https://doi.org/10.1038/sj.leu.2403560
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403560
Keywords
This article is cited by
-
The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer’s disease pathogenesis
Molecular Neurodegeneration (2016)
-
Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer
Cancer Chemotherapy and Pharmacology (2014)
-
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
Blood Cancer Journal (2012)
-
Tyrosine dephosphorylation is required for Bak activation in apoptosis
The EMBO Journal (2010)
-
Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease
Immunologic Research (2008)